The World Congress on NeuroTherapeutics: Dilemmas, Debates & Discussions (DDDN) is a comprehensive Congress fully devoted to neurotherapeutic topics, which will be held in Basel, Switzerland, September 4 – 7, 2014. The congress is aimed at interaction between medical specialists, neuroscientists and the industry. The speakers will present an overview of the fields such as Stroke, Alzheimer’s Disease, MS, etc.)
Stem Cell Therapy in Neurology
This session will deal with the hottest neurotherapeutic topic in the media. The focus will be on both neurodegeneration and inflammatory CNS diseases.
Practical Abstract Session — Therapeutic Dilemmas
Selected complicated cases, submitted by the participants in advance, to be discussed by a panel of experts
The Future of Neurotherapeutics
This session is aimed at interaction between medical specialists, neuroscientists and the industry. The speakers (experts or field investigators) will present an overview of the future in their fields (stroke, Alzheimer, ALS, MS) and will allow comments from the audience.
Disease Modifying Drugs for Multiple Sclerosis: What should be the Endpoints in Clinical Trials?
This session is aimed at neurologists (clinicians and academicians) caring for MS patients or involved in therapeutic trials. It will present the topic in a debate format.
Acute Therapy for Stroke
This session is for a mixed crowd of in hospital and outpatient neurologists. It deals with the most prevalent disabling neurological conditions at a time of fast development in this field.
Dilemmas of Neurological Therapy Practice during Pregnancy
This session is aimed at the practicing neurologist (in hospital or outpatient clinic). It deals with common neurological disorders in pregnant women. Special time will be available for the audience to raise issues related to neurological therapy during pregnancy in a Q & A format.
Therapeutic Brain Stimulation (Electric and Magnetic)
This session is devoted to functional neurotherapeutics in common neurological diseases. It is aimed at neuroscientists and neurosurgeons in addition to neurologists.
Therapeutic Dilemmas in Multiple Sclerosis
This session is for a mixed crowd of neuroimmunological specialists and practicing neurologists. It deals with practical issues in the advanced MS patient.
The Ethics of Human Therapy Trials
IRBs have become an essential element of clinical trial. Have they become a hurdle? The session will focus on the various administrative and legal aspects of the system and will conclude with a debate.
Neurological (Cognitive) Enhancement
This session touches upon an emerging controversial topic in neurotherapy: should we medicate or otherwise treat the ‘normal’ subject? Practical and ethical issues will be raised.
This session is aimed at the practicing and academic neurologist. It will present new approaches as well as common practical dilemmas with ample time for expert opinion and audience input.
Steroids in Neurological Diseases
A practical session dealing with controversial topics when prescribing steroids in neurological diseases: Should they be used and how? Time will be allowed for the audience to raise questions and meet the experts.
Serono Symposia International Foundation will submit the main congress program of the World Congress on Controversies in Neurology (DDDN), Basel, Switzerland, September 4 – 7, 2014, for accreditation by the European Accreditation Council for Continuing Medical Education (EACCME).
For the Italian participants
The World Congress on Controversies in Neurology (DDDN), Basel, Switzerland, September 4 – 7, 2014 program will be submitted for CME accreditation from the Italian Ministry of Health.
The CME accreditation is valid for the main congress program only and does not cover the company-sponsored symposia.
ISO 9001 Certification
Serono Symposia International Foundation has received the ISO 9001 Certification of Quality Management Systems. This Quality certification requires all participants to fill in a scientific questionnaire and to evaluate the overall quality of the event. Questionnaires will be distributed onsite during the congress.
CME for USA participants
UEMS/EACCME CME credit recognition
The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialties (UEMS). Under the terms of this agreement, the AMA will convert CME credit certified by the European Accreditation Council for Continuing Medical Education (EACCME), the accrediting arm of the UEMS, to AMA PRA Category 1 Credit™. Physicians (MDs, DOs or equivalent international degree) may have their EACCME credit converted to AMA PRA Category 1 Credit™ by applying to the AMA.